Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2834
https://www.abbvie.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc
Here’s Why AbbVie (ABBV) Rose in Q3
- Dec 5th, 2023 4:00 am
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
- Dec 4th, 2023 5:19 pm
Optimism for AbbVie (NYSE:ABBV) has grown this past week, despite five-year decline in earnings
- Dec 4th, 2023 2:01 pm
2 Dividend Stocks to Buy and Hold Forever
- Dec 2nd, 2023 3:00 pm
5 S&P 500 Stocks That Pay a Generous Dividend
- Dec 2nd, 2023 12:30 pm
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript
- Dec 1st, 2023 2:58 pm
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
- Dec 1st, 2023 1:13 pm
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
- Dec 1st, 2023 10:55 am
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
- Dec 1st, 2023 2:51 am
Why Abbvie Stock Popped Today
- Dec 1st, 2023 12:19 am
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
- Nov 30th, 2023 9:22 pm
This Combination of 3 Stocks Provides Monthly Income
- Nov 30th, 2023 9:05 pm
AbbVie to acquire ImmunoGen in $10B deal
- Nov 30th, 2023 8:48 pm
AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study
- Nov 30th, 2023 4:56 pm
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio
- Nov 30th, 2023 4:49 pm
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
- Nov 30th, 2023 4:07 pm
ImmunoGen Stock Soars 81% on AbbVie’s $10.1 Billion Takeover
- Nov 30th, 2023 3:40 pm
AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion
- Nov 30th, 2023 3:37 pm
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
- Nov 30th, 2023 3:08 pm
Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout
- Nov 30th, 2023 2:44 pm
Scroll